Translational strategies in aging and age-related disease
- PMID: 26646495
- PMCID: PMC8785908
- DOI: 10.1038/nm.4004
Translational strategies in aging and age-related disease
Abstract
Aging is a risk factor for several of the world's most prevalent diseases, including neurodegenerative disorders, cancer, cardiovascular disease and metabolic disease. Although our understanding of the molecular pathways that contribute to the aging process and age-related disease is progressing through the use of model organisms, how to apply this knowledge in the clinic is less clear. In September, Nature Medicine, in collaboration with the Volkswagen Foundation, hosted a conference at the beautiful Herrenhausen Palace in Hannover, Germany with the goal of broadening our understanding of the aging process and its meaning as a 'risk factor' in disease. Here, several of the speakers at that conference answer questions posed by Nature Medicine.
Conflict of interest statement
COMPETING FINANCIAL INTERESTS
The authors declare competing financial interests: details are available in the
References
-
- Richardson A et al. J. Gerontol. A Biol. Sci. Med. Sci (2015).
-
- The National Coalition for Cancer Survivorship. Pazdur: “The primary endpoint of every trial should be the patient.” The Cancer Letter http://www.cancerletter.com/articles/20151023_6 (23 October 2015)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
